PEACE 2 results: Evaluating pelvic RT for very high-risk PCa

In this episode, UROONCO PCa associate editor Dr. Jennifer Le Guévelou speaks with radiation oncologist Prof. Pierre Blanchard on the results of the PEACE 2 phase III randomised trial investigating prophylactic pelvic radiotherapy (RT) targeting pelvic nodal micrometastases and/or cabazitaxel may both reduce the risk of relapse and improve outcomes in patients with very high-risk localised prostate cancer. They discuss the design of the PEACE 2 trial, and its key findings, which showed that w...